0000059255-15-000090.txt : 20160216 0000059255-15-000090.hdr.sgml : 20160215 20150915120416 ACCESSION NUMBER: 0000059255-15-000090 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20150915 FILER: COMPANY DATA: COMPANY CONFORMED NAME: VALHI INC /DE/ CENTRAL INDEX KEY: 0000059255 STANDARD INDUSTRIAL CLASSIFICATION: INDUSTRIAL INORGANIC CHEMICALS [2810] IRS NUMBER: 870110150 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 5430 LBJ FRWY STREET 2: STE 1700 CITY: DALLAS STATE: TX ZIP: 75240 BUSINESS PHONE: 9722331700 MAIL ADDRESS: STREET 1: THREE LINCOLN CENTER STREET 2: 5430 LBJ FREEWAY SUITE 1700 CITY: DALLAS STATE: TX ZIP: 75240 FORMER COMPANY: FORMER CONFORMED NAME: LLC CORP DATE OF NAME CHANGE: 19870329 FORMER COMPANY: FORMER CONFORMED NAME: LIBERTY LOAN CORP DATE OF NAME CHANGE: 19800414 CORRESP 1 filename1.htm
VALHI, INC.
5430 LBJ Freeway, Suite 1700
Dallas, Texas  75240

FOIA CONFIDENTIAL TREATMENT REQUEST BY VALHI, INC.


September 15, 2015

U.S. Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549

Attention:                        Mr. Terence O'Brien, Accounting Branch Chief
Division of Corporation Finance

CC:                                              Ms. Tracie Mariner
Division of Corporation Finance

Ms. Jeanne Baker
Division of Corporation Finance

RE:              Valhi, Inc.
Form 10-Q for Fiscal Quarter Ended June 30, 2015 Filed August 7, 2015
File No. 333-48391

Dear Mr. O'Brien

Exhibit A to this letter, pages 1 through 5 thereof (collectively, the "Information"), is hereby submitted to you in response to the Staff's letter dated August 31, 2015 (the "Comment Letter") concerning the above referenced Forms 10-Q of Valhi, Inc. ("Valhi").  The Information is being supplementally provided to you in response to comment number 1 in the Comment Letter.

Pursuant to 17 C.F.R. § 200.83(c), the undersigned hereby requests on behalf of Valhi that the Commission afford the Information confidential treatment for reasons of business confidentiality, and that no portion thereof be disclosed if a request for disclosure is made under the Freedom of Information Act, 5 U.S.C. § 522.  Pursuant to the Commission Rule of Information Request, 17 C.F.R. § 200.83, each page of the Information is clearly marked "Confidential Treatment Requested."

If you have any questions, you may contact the undersigned at 972-450-4228.

Securities and Exchange Commission
September 15, 2015
Page 2



Sincerely,



/s/ Gregory M. Swalwell                 
Gregory M. Swalwell,
Executive Vice President and Controller

CC:            Office of Freedom of Information and Privacy Act Operations   (w/o enclosure)
            Securities and Exchange Commission
            U.S. Securities and Exchange Commission
100 F Street, N.E.
Mail Stop 2736
Washington, D.C. 20549


Exhibit A – Page 1 of 5
Document Supplementally Provided to the Securities and Exchange Commission September 15, 2015
Confidential Treatment Requested by Valhi, Inc.
Pre-tax Income (Loss) Generated by German and Belgian Jurisdictions



   
Germany
   
   
Corporate
 
Trade
   
   
Tax
 
Tax
 
Belgium
   
(In euro millions)
             
Year ended December 31, 2012
 
[*]
 
[*]
 
[*]
             
Year ended December 31, 2013
 
[*]
 
[*]
 
[*]
             
Year ended December 31, 2014
 
[*]
 
[*]
 
[*]
             
Quarter ended March 31, 2015
 
[*]
 
[*]
 
[*]
             
Six months ended June 30, 2015
 
[*]
 
[*]
 
[*]

[*] Information omitted pursuant to a request for confidential treatment filed with the SEC by Valhi, Inc.



Exhibit A – Page 2 of 5
Document Supplementally Provided to the Securities and Exchange Commission September 15, 2015
Confidential Treatment Requested by Valhi, Inc.
German and Belgian NOL Carryforwards


   
Germany
   
   
Corporate
 
Trade
   
   
Tax
 
Tax
 
Belgium
   
(In euro millions)
             
March 31, 2015
 
[*]
 
[*]
 
[*]
             
June 30, 2015
 
[*]
 
[*]
 
[*]

[*] Information omitted pursuant to a request for confidential treatment filed with the SEC by Valhi, Inc.



Exhibit A – Page 3 of 5
Document Supplementally Provided to the Securities and Exchange Commission September 15, 2015
Confidential Treatment Requested by Valhi, Inc.
Expected Level of Pre-Tax Profits For Calendar 2015 For German and Belgian Operations



   
Germany
 
Belgium
   
(In $ millions)
         
Actual pre-tax profits - year ended
     
  December 31, 2014
 
[*]
 
[*]
         
Expected level of pre-tax profit
       
 (loss) for calendar 2015 at:
       
    December 31, 2014
 
[*]
 
[*]
         
    March 31, 2015
 
[*]
 
[*]
         
    June 30, 2015
 
[*]
 
[*]


[*] Information omitted pursuant to a request for confidential treatment filed with the SEC by Valhi, Inc.




Exhibit A – Page 4 of 5
Document Supplementally Provided to the Securities and Exchange Commission September 15, 2015
Confidential Treatment Requested by Valhi, Inc.
Sales For German and Belgian Operations

   
 
Sales
 
   
Germany
 
Belgium
   
(In $ millions)
         
Year ended December 31, 2013
 
[*]
 
[*]
         
Year ended December 31, 2014
 
[*]
 
[*]
         
Quarter ended March 31, 2014
 
[*]
 
[*]
         
Quarter ended March 31, 2015
 
[*]
 
[*]
         
Quarter ended June 30, 2014
 
[*]
 
[*]
         
Quarter ended June 30, 2015
 
[*]
 
[*]
         
Six months ended June 30, 2014
 
[*]
 
[*]
         
Six months ended June 30, 2015
 
[*]
 
[*]


[*] Information omitted pursuant to a request for confidential treatment filed with the SEC by Valhi, Inc.






Exhibit A – Page 5 of 5
Document Supplementally Provided to the Securities and Exchange Commission September 15, 2015
Confidential Treatment Requested by Valhi, Inc.
Gross Margin For German and Belgian Operations


   
 
Gross Margin
 
   
Germany
 
Belgium
   
(In $ millions)
         
Year ended December 31, 2013
 
[*]
 
[*]
         
Year ended December 31, 2014
 
[*]
 
[*]
         
Quarter ended March 31, 2014
 
[*]
 
[*]
         
Quarter ended March 31, 2015
 
[*]
 
[*]
         
Quarter ended June 30, 2014
 
[*]
 
[*]
         
Quarter ended June 30, 2015
 
[*]
 
[*]
         
Six months ended June 30, 2014
 
[*]
 
[*]
         
Six months ended June 30, 2015
 
[*]
 
[*]

[*] Information omitted pursuant to a request for confidential treatment filed with the SEC by Valhi, Inc.